Transcriptional profiling of diabetic neuropathy in the BKS db/db mouse

A model of type 2 diabetes

Manjusha Pande, Junguk Hur, Yu Hong, Carey Backus, John M. Hayes, Sang Su Oh, Matthias Kretzler, Eva L. Feldman

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

OBJECTIVE - A better understanding of the molecular mechanisms underlying the development and progression of diabetic neuropathy (DN) is essential for the design of mechanism-based therapies. We examined changes in global gene expression to define pathways regulated by diabetes in peripheral nerve. RESEARCH DESIGN AND METHODS - Microarray data for 24-week-old BKS db/db and db/+ mouse sciatic nerve were analyzed to define significantly differentially expressed genes (DEGs); DEGs were further analyzed to identify regulated biological processes and pathways. Expression profile clustering was performed to identify coexpressed DEGs. A set of coexpressed lipid metabolism genes was used for promoter sequence analysis. RESULTS - Gene expression changes are consistent with structural changes of axonal degeneration. Pathways regulated in the db/db nerve include lipid metabolism, carbohydrate metabolism, energy metabolism, peroxisome proliferator-activated receptor signaling, apoptosis, and axon guidance. Promoter sequences of lipid metabolism-related genes exhibit evidence of coregulation of lipid metabolism and nervous system development genes. CONCLUSIONS - Our data support existing hypotheses regarding hyperglycemia-mediated nerve damage in DN. Moreover, our analyses revealed a possible coregulation mechanism connecting hyperlipidemia and axonal degeneration.

Original languageEnglish (US)
Pages (from-to)1981-1989
Number of pages9
JournalDiabetes
Volume60
Issue number7
DOIs
StatePublished - Jul 1 2011

Fingerprint

Diabetic Neuropathies
Type 2 Diabetes Mellitus
Lipid Metabolism
Genes
Biological Phenomena
Gene Expression
Peroxisome Proliferator-Activated Receptors
Carbohydrate Metabolism
Sciatic Nerve
Hyperlipidemias
Peripheral Nerves
Hyperglycemia
Energy Metabolism
Nervous System
Sequence Analysis
Cluster Analysis
Research Design
Apoptosis

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Pande, M., Hur, J., Hong, Y., Backus, C., Hayes, J. M., Oh, S. S., ... Feldman, E. L. (2011). Transcriptional profiling of diabetic neuropathy in the BKS db/db mouse: A model of type 2 diabetes. Diabetes, 60(7), 1981-1989. https://doi.org/10.2337/db10-1541

Transcriptional profiling of diabetic neuropathy in the BKS db/db mouse : A model of type 2 diabetes. / Pande, Manjusha; Hur, Junguk; Hong, Yu; Backus, Carey; Hayes, John M.; Oh, Sang Su; Kretzler, Matthias; Feldman, Eva L.

In: Diabetes, Vol. 60, No. 7, 01.07.2011, p. 1981-1989.

Research output: Contribution to journalArticle

Pande, M, Hur, J, Hong, Y, Backus, C, Hayes, JM, Oh, SS, Kretzler, M & Feldman, EL 2011, 'Transcriptional profiling of diabetic neuropathy in the BKS db/db mouse: A model of type 2 diabetes', Diabetes, vol. 60, no. 7, pp. 1981-1989. https://doi.org/10.2337/db10-1541
Pande, Manjusha ; Hur, Junguk ; Hong, Yu ; Backus, Carey ; Hayes, John M. ; Oh, Sang Su ; Kretzler, Matthias ; Feldman, Eva L. / Transcriptional profiling of diabetic neuropathy in the BKS db/db mouse : A model of type 2 diabetes. In: Diabetes. 2011 ; Vol. 60, No. 7. pp. 1981-1989.
@article{feb30b2d64114202838316aa21090da6,
title = "Transcriptional profiling of diabetic neuropathy in the BKS db/db mouse: A model of type 2 diabetes",
abstract = "OBJECTIVE - A better understanding of the molecular mechanisms underlying the development and progression of diabetic neuropathy (DN) is essential for the design of mechanism-based therapies. We examined changes in global gene expression to define pathways regulated by diabetes in peripheral nerve. RESEARCH DESIGN AND METHODS - Microarray data for 24-week-old BKS db/db and db/+ mouse sciatic nerve were analyzed to define significantly differentially expressed genes (DEGs); DEGs were further analyzed to identify regulated biological processes and pathways. Expression profile clustering was performed to identify coexpressed DEGs. A set of coexpressed lipid metabolism genes was used for promoter sequence analysis. RESULTS - Gene expression changes are consistent with structural changes of axonal degeneration. Pathways regulated in the db/db nerve include lipid metabolism, carbohydrate metabolism, energy metabolism, peroxisome proliferator-activated receptor signaling, apoptosis, and axon guidance. Promoter sequences of lipid metabolism-related genes exhibit evidence of coregulation of lipid metabolism and nervous system development genes. CONCLUSIONS - Our data support existing hypotheses regarding hyperglycemia-mediated nerve damage in DN. Moreover, our analyses revealed a possible coregulation mechanism connecting hyperlipidemia and axonal degeneration.",
author = "Manjusha Pande and Junguk Hur and Yu Hong and Carey Backus and Hayes, {John M.} and Oh, {Sang Su} and Matthias Kretzler and Feldman, {Eva L.}",
year = "2011",
month = "7",
day = "1",
doi = "10.2337/db10-1541",
language = "English (US)",
volume = "60",
pages = "1981--1989",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "7",

}

TY - JOUR

T1 - Transcriptional profiling of diabetic neuropathy in the BKS db/db mouse

T2 - A model of type 2 diabetes

AU - Pande, Manjusha

AU - Hur, Junguk

AU - Hong, Yu

AU - Backus, Carey

AU - Hayes, John M.

AU - Oh, Sang Su

AU - Kretzler, Matthias

AU - Feldman, Eva L.

PY - 2011/7/1

Y1 - 2011/7/1

N2 - OBJECTIVE - A better understanding of the molecular mechanisms underlying the development and progression of diabetic neuropathy (DN) is essential for the design of mechanism-based therapies. We examined changes in global gene expression to define pathways regulated by diabetes in peripheral nerve. RESEARCH DESIGN AND METHODS - Microarray data for 24-week-old BKS db/db and db/+ mouse sciatic nerve were analyzed to define significantly differentially expressed genes (DEGs); DEGs were further analyzed to identify regulated biological processes and pathways. Expression profile clustering was performed to identify coexpressed DEGs. A set of coexpressed lipid metabolism genes was used for promoter sequence analysis. RESULTS - Gene expression changes are consistent with structural changes of axonal degeneration. Pathways regulated in the db/db nerve include lipid metabolism, carbohydrate metabolism, energy metabolism, peroxisome proliferator-activated receptor signaling, apoptosis, and axon guidance. Promoter sequences of lipid metabolism-related genes exhibit evidence of coregulation of lipid metabolism and nervous system development genes. CONCLUSIONS - Our data support existing hypotheses regarding hyperglycemia-mediated nerve damage in DN. Moreover, our analyses revealed a possible coregulation mechanism connecting hyperlipidemia and axonal degeneration.

AB - OBJECTIVE - A better understanding of the molecular mechanisms underlying the development and progression of diabetic neuropathy (DN) is essential for the design of mechanism-based therapies. We examined changes in global gene expression to define pathways regulated by diabetes in peripheral nerve. RESEARCH DESIGN AND METHODS - Microarray data for 24-week-old BKS db/db and db/+ mouse sciatic nerve were analyzed to define significantly differentially expressed genes (DEGs); DEGs were further analyzed to identify regulated biological processes and pathways. Expression profile clustering was performed to identify coexpressed DEGs. A set of coexpressed lipid metabolism genes was used for promoter sequence analysis. RESULTS - Gene expression changes are consistent with structural changes of axonal degeneration. Pathways regulated in the db/db nerve include lipid metabolism, carbohydrate metabolism, energy metabolism, peroxisome proliferator-activated receptor signaling, apoptosis, and axon guidance. Promoter sequences of lipid metabolism-related genes exhibit evidence of coregulation of lipid metabolism and nervous system development genes. CONCLUSIONS - Our data support existing hypotheses regarding hyperglycemia-mediated nerve damage in DN. Moreover, our analyses revealed a possible coregulation mechanism connecting hyperlipidemia and axonal degeneration.

UR - http://www.scopus.com/inward/record.url?scp=80052101888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052101888&partnerID=8YFLogxK

U2 - 10.2337/db10-1541

DO - 10.2337/db10-1541

M3 - Article

VL - 60

SP - 1981

EP - 1989

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 7

ER -